A Series of 1,10-Phenanthroline and Prodigiosin Derivatives as Highly Potent and Effective New Anticancer Therapeutic Drugs against mTOR and HDAC Enzymes

Project Title: A Series of 1,10-Phenanthroline and Prodigiosin Derivatives as Highly Potent and Effective New Anticancer Therapeutic Drugs against mTOR and HDAC Enzymes
Role in the Project: Principal Investigator
Project Dates: Sep 2022 – Current (24 MONTHS)
Funded by: KHAS_SEED & BAF, Institutional Funding, Istanbul, TÜRKİYE